ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,974Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 2035

$522K Total Retail Price of All Prescriptions

Rank: 277 out of 2035

482 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 10,975 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
FUROSEMIDE 618 587 1 7
LEVOTHYROXINE SODIUM 509 482 2 4
POTASSIUM CHLORIDE 464 453 3 18
SIMVASTATIN 463 386 4 1
METOPROLOL TARTRATE 364 334 5 8
AMLODIPINE BESYLATE 332 317 6 6
LISINOPRIL 327 302 7 3
HYDROCODONE-ACETAMINOPHEN 308 285 S3 8 2
OMEPRAZOLE 287 258 9 5
WARFARIN SODIUM 259 247 10 11
MIRTAZAPINE 229 229 11 46
DONEPEZIL HCL 226 217 12 24
NAMENDA 220 220 13 37
ISOSORBIDE MONONITRATE ER 161 152 14 32
ESCITALOPRAM OXALATE 159 139 15 77
METFORMIN HCL 158 122 16 9
CITALOPRAM HBR 157 155 17 20
SERTRALINE HCL 146 140 18 23
QUETIAPINE FUMARATE 129 117 19 70
METOPROLOL SUCCINATE 119 104 20 16
ATENOLOL 117 115 21 10
POLYETHYLENE GLYCOL 3350 111 82 22 48
CARVEDILOL 110 98 23 22
RISPERIDONE 110 108 23 68
FAMOTIDINE 110 99 23 71
TAMSULOSIN HCL 104 104 26 25
SEROQUEL 92 85 27 153
RAMIPRIL 91 91 28 135
PAROXETINE HCL 90 81 29 69
DIGOXIN 89 89 30 67
PANTOPRAZOLE SODIUM 88 84 31 42
GABAPENTIN 88 86 31 14
DIVALPROEX SODIUM 87 87 33 75
SPIRONOLACTONE 82 78 34 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 79 35 110
GLIMEPIRIDE 81 76 35 55
LACTULOSE 80 42 37 96
TRAMADOL HCL 79 79 38 19
LOSARTAN POTASSIUM 71 71 39 15
RANITIDINE HCL 67 57 40 28
ALENDRONATE SODIUM 66 66 41 27
CIPROFLOXACIN HCL 63 49 42 63
CARBIDOPA-LEVODOPA 62 62 43 94
HYDRALAZINE HCL 62 61 43 45
ALLOPURINOL 59 59 45 34
ADVAIR DISKUS 59 54 45 38
LOVASTATIN 56 30 47 33
CLOPIDOGREL 54 54 48 30
LEVOFLOXACIN 54 52 48 99
TRIAMTERENE-HCTZ 54 51 48 35
TRAZODONE HCL 50 50 51 50
VENLAFAXINE HCL ER 50 50 51 130
OXYBUTYNIN CHLORIDE 50 49 51 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.